Zacks Research Issues Optimistic Forecast for MD Earnings

Pediatrix Medical Group, Inc. (NYSE:MD) – Equities research analysts at Zacks Research boosted their Q1 2026 EPS estimates for Pediatrix Medical Group in a note issued to investors on Tuesday, August 19th. Zacks Research analyst Team now expects that the company will post earnings of $0.25 per share for the quarter, up from their prior estimate of $0.24. Zacks Research has a “Strong-Buy” rating on the stock. The consensus estimate for Pediatrix Medical Group’s current full-year earnings is $1.38 per share. Zacks Research also issued estimates for Pediatrix Medical Group’s Q2 2026 earnings at $0.41 EPS.

Pediatrix Medical Group (NYSE:MD) last released its earnings results on Tuesday, August 5th. The company reported $0.53 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.42 by $0.11. Pediatrix Medical Group had a net margin of 5.66% and a return on equity of 18.94%. The firm had revenue of $468.84 million during the quarter, compared to the consensus estimate of $464.37 million. During the same period in the previous year, the firm earned $0.34 earnings per share. Pediatrix Medical Group’s revenue was down 7.1% compared to the same quarter last year.

MD has been the subject of several other reports. Macquarie boosted their price objective on shares of Pediatrix Medical Group from $19.00 to $20.00 and gave the stock an “outperform” rating in a research note on Thursday, May 8th. UBS Group boosted their price objective on shares of Pediatrix Medical Group from $16.00 to $16.50 and gave the stock a “neutral” rating in a research note on Thursday, August 14th. One equities research analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating and four have assigned a Hold rating to the company. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $16.75.

Pediatrix Medical Group Price Performance

MD opened at $16.9730 on Friday. The company has a quick ratio of 1.80, a current ratio of 1.80 and a debt-to-equity ratio of 0.70. Pediatrix Medical Group has a 52-week low of $10.06 and a 52-week high of $17.67. The company has a 50 day moving average of $13.76 and a two-hundred day moving average of $13.93. The company has a market cap of $1.48 billion, a P/E ratio of 13.16 and a beta of 1.21.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in the stock. Nomura Holdings Inc. boosted its stake in Pediatrix Medical Group by 121.4% during the 2nd quarter. Nomura Holdings Inc. now owns 576,730 shares of the company’s stock valued at $8,276,000 after acquiring an additional 316,274 shares during the last quarter. Caxton Associates LLP bought a new position in Pediatrix Medical Group during the 2nd quarter valued at $236,000. Public Sector Pension Investment Board boosted its stake in Pediatrix Medical Group by 7.1% during the 2nd quarter. Public Sector Pension Investment Board now owns 287,060 shares of the company’s stock valued at $4,119,000 after acquiring an additional 18,984 shares during the last quarter. CANADA LIFE ASSURANCE Co raised its holdings in shares of Pediatrix Medical Group by 5.5% during the second quarter. CANADA LIFE ASSURANCE Co now owns 72,638 shares of the company’s stock worth $1,043,000 after purchasing an additional 3,767 shares during the period. Finally, Tower Research Capital LLC TRC raised its holdings in shares of Pediatrix Medical Group by 219.3% during the second quarter. Tower Research Capital LLC TRC now owns 7,685 shares of the company’s stock worth $110,000 after purchasing an additional 5,278 shares during the period. 97.71% of the stock is currently owned by institutional investors.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.